Real‐world use of diagnostic tests for mild cognitive impairment, Alzheimer's disease, and other dementias in Medicare fee‐for‐service beneficiaries

Abstract INTRODUCTION This study assessed real‐world use of diagnostic tests, such as neuroimaging (e.g., magnetic resonance imaging [MRI], or positron emission tomography [PET]), and computed tomography (CT), cerebrospinal fluid (CSF) biomarker, and blood tests for mild cognitive impairment (MCI),...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Jessie T. Yan, Allison Dillon, Tong Meng, Viviktha Ramesh, Marwan Noel Sabbagh, Vishakha Sharma, Sophie Roth
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2025-07-01
coleção:	Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
Assuntos:	Alzheimer's disease biomarker cerebrospinal fluid dementia diagnostic test use mild cognitive impairment
Acesso em linha:	https://doi.org/10.1002/dad2.70156
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!